Anzeige
Mehr »
Login
Montag, 27.09.2021 Börsentäglich über 12.000 News von 673 internationalen Medien
LUKRATIVE NEUVORSTELLUNG IM MEGA-WACHSTUMSMARKT
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PSNF ISIN: US6300873022 Ticker-Symbol: NV3P 
Tradegate
24.09.21
17:15 Uhr
4,300 Euro
-0,176
-3,93 %
Branche
Nanotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
NANOVIRICIDES INC Chart 1 Jahr
5-Tage-Chart
NANOVIRICIDES INC 5-Tage-Chart
RealtimeGeldBriefZeit
4,2284,45224.09.

Aktuelle News zur NANOVIRICIDES Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiNanoViricides, Inc.: Significantly Improved Safety Profile and Metabolism of Remdesivir Observed Due to Encapsulation in NanoViricides Drug Candidate Enabling Potential Highly Effective Pan-Coronavirus Antiviral Drug278SHELTON, Conn., Sept. 22, 2021 /PRNewswire/ -- NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel...
► Artikel lesen
MiXFRA NV3P: WIEDERAUFNAHME/RESUMPTION163FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
DiNNVC Stock: What Is Going on With Red-Hot NanoViricides Today?11
NANOVIRICIDES Aktie jetzt für 0€ handeln
DiWhat Is a 'News Pending' Halt? What to Know as NNVC Stock Captivates Investors2
DiNanoViricides surges 60% on COVID remdesivir encapsulation data8
DiNNVC, RWLK and INDI among mid-day movers32
DiReWalk Robotics, NanoViricides leads healthcare gainers; Edesa Biotech, Verrica Pharmaceuticals among major losers55
DiXFRA NV3P: AUSSETZUNG/SUSPENSION217DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILNANOVIRICIDES NEW...
► Artikel lesen
DiEXCLUSIVE: NanoViricides' Remdesivir-Encapsulated COVID-19 Therapy Shows Encouraging Preclinical Safety Profile32
15.09.YY, NNVC and REKR among mid-day movers2
14.09.NanoViricides Completes Licensing for Coronavirus Field which Includes Current COVID-19 Drug Development10
14.09.EXCLUSIVE: NanoViricides Beefs Up Its COVID-19 Pipeline With TheraCour Licensing Pact4
22.06.NanoViricides Review: What you Need to Know About the Company15
17.05.NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending March 31, 2021 - Has Sufficient Cash, Coronavirus Drug Candidate Moving Towards IND1.291SHELTON, CT / ACCESSWIRE / May 17, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines...
► Artikel lesen
14.05.NANOVIRICIDES, INC. - 10-Q, Quaterly Report3
04.05.XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 04.05.20212.319The following instruments on XETRA do have their first trading 04.05.2021 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag am 04.05.2021 Aktien 1 NO0010895568 Airthings AS 2 ES0105148003...
► Artikel lesen
09.03.NanoViricides, Inc. Pan-coronavirus COVID-19 Drug Candidates Are Highly Effective in Pre-clinical Animal Studies in Support of FDA Pre-IND Application1.242SHELTON, CT / ACCESSWIRE / March 9, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company"), a leader in the development of highly effective antiviral therapies based on a novel nanomedicines...
► Artikel lesen
02.03.NanoViricides, Inc. Pan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinical Cell Culture Studies Performed in Preparation of FDA Pre-IND Application839SHELTON, CT / ACCESSWIRE / March 2, 2021 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicine...
► Artikel lesen
17.02.NanoViricides, Inc.: NanoViricides Has Filed Quarterly Report for Period Ending December 31, 2020 - Has Sufficient Cash, Coronavirus Drug Candidate Safe in GLP Safety Toxicology Moving Towards IND1.732SHELTON, CT / ACCESSWIRE / February 17, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines...
► Artikel lesen
08.02.NanoViricides, Inc.: NanoViricides's Broad-Spectrum Antiviral Drug Candidate for the Treatment of COVID-19 Infections was Well Tolerated in GLP and non-GLP Animal Safety Studies1.494SHELTON, CT / ACCESSWIRE / February 8, 2021 / NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the development of highly effective broad-spectrum antiviral therapies based...
► Artikel lesen
Seite:  Weiter >>
25 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1